A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
Chilcott
J
J
School of Health and Related Research, University of Sheffield, UK.
Lloyd Jones
M
M
Wight
J
J
Forman
K
K
Wray
J
J
Beverley
C
C
Tappenden
P
P
D003362:Cost-Benefit Analysis; D004899:Erythroblastosis, Fetal / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000191:economics / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D018029:Rho(D) Immune Globulin / Q000191:economics* / Q000627:therapeutic use*; D006113:United Kingdom
D007518:Isoantibodies; C061961:RHO(D) antibody; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin